Cambridge Healthtech Institute’s 4th Annual
Breakthroughs in Cell Therapy
August 11, 2025
Join us at Cambridge Healthtech Institute's 4th Annual Breakthroughs in Cell Therapy conference, where we celebrate recent clinical achievements and harness their insights to drive the development of effective and innovative cell-based therapeutics. This year, we spotlight solid tumor treatment, exploring cutting-edge advancements such as in vivo CAR T, allogenic vs. autologous approaches, tumor-infiltrating lymphocytes (TILs), T cell receptors (TCRs), T regulatory cells (TREGs), and natural killer (NK) cells. We examine strategies for combining multiple cell-based therapies together to increase efficacy. Here we have critical discussions to tackle barriers and considerations for clinical translation, including overcoming attrition, balancing cost and speed, and navigating regulatory complexities. Join us to share insights, advance collaboration, and shape the next generation of adoptive cell therapies for solid tumors.
Who should attend:
- Biotech founders in IO
- Pharma directors
- Principal and senior scientists
- IO professors and post-docs
- Immunologists and oncologists
- Computational biologists
- Regulatory affairs specialists
- Clinical trial managers
- Those researching:
- CAR-Ts, TILs, TREGs, TCRs, and/or NK cells
- Cell therapy
Coverage will include, but is not limited to:
Adoptive Cell Therapy Advancements for Solid Tumors
- CAR T therapy
o In vivo CAR T
- Tumor-Infiltrating Lymphocytes (TILs) and T Cell Receptors (TCRs)
- T Regulatory Cells (TREGs)
- NK cells
- Other emerging cell-based therapies
o CAR-macrophage
o CAR-gamma/delta T cells
From Lab to Clinic: Overcoming Barriers to Translational Success
- Preventing attrition in the clinic
- Overcoming cost barriers
o Allogenic vs. autologous approaches: balancing efficacy, cost, and speed
- Overcoming regulatory barriers
The deadline for priority consideration is January 31, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: